What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Gene
Internal medicine, Cardiology, Myocardial infarction, Ischemia and Reperfusion injury are his primary areas of study.
His study looks at the intersection of Internal medicine and topics like Endocrinology with Wortmannin.
His Myocardial infarction study integrates concerns from other disciplines, such as Ejection fraction, Angioplasty and Cause of death.
His Ischemia research integrates issues from Necrosis, Artery and Anesthesia.
His research in Anesthesia intersects with topics in Reperfusion therapy, Myocardial stunning, Coronary occlusion and Mitochondrial permeability transition pore.
His Reperfusion injury research incorporates themes from Cardioprotection and Cell biology.
His most cited work include:
- Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. (1104 citations)
- Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction (1098 citations)
- Postconditioning the Human Heart (874 citations)
What are the main themes of his work throughout his whole career to date?
Michel Ovize spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Ischemia and Anesthesia.
His Internal medicine study frequently draws connections between related disciplines such as Endocrinology.
His work in the fields of Myocardial infarction, such as Infarction and Reperfusion therapy, intersects with other areas such as In patient.
His Ischemia research is multidisciplinary, incorporating elements of Necrosis and Occlusion.
His research on Anesthesia frequently connects to adjacent areas such as Circulatory system.
His work carried out in the field of Reperfusion injury brings together such families of science as Heart metabolism, Cardioprotection and Mitochondrial permeability transition pore.
He most often published in these fields:
- Internal medicine (60.63%)
- Cardiology (50.00%)
- Myocardial infarction (36.21%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (60.63%)
- Cardiology (50.00%)
- Myocardial infarction (36.21%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Heart failure and Percutaneous coronary intervention.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
His Cardiology research includes elements of Stroke, Magnetic resonance imaging and Cohort.
His Myocardial infarction study combines topics from a wide range of disciplines, such as Prospective cohort study, Cardiac magnetic resonance imaging and Ischemia.
His biological study spans a wide range of topics, including Inflammation and Pharmacology.
His studies in Cardioprotection integrate themes in fields like Mitochondrion, Cell biology, Intensive care medicine and Programmed cell death.
Between 2017 and 2021, his most popular works were:
- Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. (194 citations)
- Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. (191 citations)
- The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology (59 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Myocardial infarction
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Cardioprotection and Stroke.
The Acute ischemic stroke, Collateral circulation and Cardiac surgery research Michel Ovize does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Monocyte Chemoattractant Proteins and Protocol, therefore creating a link between diverse domains of science.
In general Cardiology, his work in Reperfusion injury and Reperfusion therapy is often linked to Matrix metalloproteinase 9 linking many areas of study.
His Myocardial infarction research includes elements of Clinical trial and Heart failure.
The subject of his Cardioprotection research is within the realm of Ischemia.
His Ischemia study frequently links to adjacent areas such as Mitochondrial permeability transition pore.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
